After hours: January 28 at 6:12:23 PM EST Loading Chart for GPCR ...

Galderma, the pure-play dermatology category leader, is pioneering new research into the impact of medication-driven <a target=_ ...

Ozempic and Wegovy do the same thing as GLP-1 would normally do for you — but to enable them to treat diabetes and obesity, ...

After hours: January 17 at 7:51:01 p.m. EST ...

Sitagliptin selectively inhibits the action of DPP-4, the primary enzyme degrading the incretin hormones, allowing glucagon-like peptide-1 and glucose-dependent insulinotropic peptide to ...

New research shows that loose or sagging skin on the face and neck is most often noted after medication-driven weight loss, with facial changes ...

There is limited real-world data evaluating outcomes of glucagon-like peptide-1 receptor agonists (GLP1-RA) use in patients with moderate to advanced CKD. Here, emulating a clinical trial ...

After hours: 7:37:25 p.m. EST ...